← All trials
NCT03394729
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 29, 2017
- Primary completion
- Nov 30, 2018
- Completion date
- Dec 21, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Federal University of Rio de JaneiroLead sponsor
- Federal University of Rio de JaneiroReponsible party - principal investigator
- Federal University of Rio de JaneiroStudy director
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.